SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biogen
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1686 75 0 BIIB
Emcee:  Harold Engstrom Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1636Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple SGermanecki-12/16/2008
1635:( Biogen Cites New Setback for MS Drug Article By KEITH J. WINSTEIN A German mopgcw-12/15/2008
1634CS: Biogen Idec. Inc. (BIIB) Neutral [V] M. Aberman CP: US$ 47.15 TP: US$ 53 CAPmopgcw-12/12/2008
1633DJ newsflash about Biogen reporting a case of leukoencephalopathy in a Tysabri ptuck-10/29/2008
1632cs: Biogen Idec. Inc. (BIIB) Neutral [V] M. Aberman CP: US$ 43.99 TP: US$ 53 CAPmopgcw-10/22/2008
1631CS: Biogen Idec. Inc. (BIIB) Neutral [V] M. Aberman CP: US$ 49.98 TP: US$ 51 CAPmopgcw-9/22/2008
1630FDA Cites Brain Virus With Genentech, Biogen Drug Associated Press September 1Doc Bones-9/12/2008
1629Biogen Idec shares gain on Tysabri outlook Associated Press 08.26.08, 11:40 AM Eclutterer-8/26/2008
1628Icahn Increases Stake in Biogen, Signaling Battle Is Far From Over By KEITH J.Doc Bones-8/13/2008
1627CS: • Conclusion: Although we expected cases of PML to occur, the two confirmed mopgcw-8/1/2008
1626sad news: wsj Biogen, Elan Report Cases of Brain Disease By KEITH WINSTEIN anmopgcw-8/1/2008
1625WSJ: Biogen Drug's Steady Return Tysabri May Hit Blockbuster Status, After 2mopgcw-7/21/2008
1624Biogen Offering $1 Billion in Notes Friday February 29, 10:13 am ET Biogen Idec tnsaf-2/29/2008
1623from gs: What's changed Biogen Idec reported 4Q2007 EPS (ex ESOs) of $0.89, mopgcw-2/7/2008
1622Drug Sales Spur Biogen's Earnings By ANDREW EDWARDS February 6, 2008 8:22 aDoc Bones-2/6/2008
1621Icahn Moves to Appoint Three to Biogen's Board By KEITH J. WINSTEIN JanuarDoc Bones-1/29/2008
1620Tysabri approved for patients failing SOC for Crohn's disease. Personally, tuck-1/14/2008
1619Biogen Gives Up Search for Suitor Biotech's Shares Drop 27% After No Bid MaDoc Bones-12/13/2007
1618Chart-wise, that drop looks seriously over done.tom pope-12/12/2007
1617<i>What happened to Icahn's (fake) bid? :-) </i> It was fake! IDewDiligence_on_SI-12/12/2007
1616What a bizzare run for this company. I can't help but feel they lost all ofmopgcw-12/12/2007
1615<<<At the conclusion of this process, Biogen Idec did not receive any drkrw-12/12/2007
1614>>Biogen Idec Completes Review of Strategic Alternatives Wednesday Decembetuck-12/12/2007
1613Medicare Cuts Payout on 2 Cancer Drugs [NYT] By ALEX BERENSON Published: DecembDoc Bones-12/7/2007
1612Biogen Gets a Dose of Skepticism Amid Deal Chatter, Critics Question Pipeline,Doc Bones-10/29/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News